[Determination of HVA and 5-HIAA in epileptic syndromes in basal conditions and after treatment with probenecid].
D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000494:pharmacology / Q000627:therapeutic use*; D001921:Brain / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D004827:Epilepsy / Q000097:blood* / Q000188:drug therapy; D006719:Homovanillic Acid / Q000097:blood*; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000097:blood*; D010648:Phenylacetates / Q000097:blood*; D011339:Probenecid / Q000494:pharmacology / Q000627:therapeutic use*; D012701:Serotonin / Q000378:metabolism
D000927:Anticonvulsants; D010648:Phenylacetates; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D011339:Probenecid; D004298:Dopamine; D006719:Homovanillic Acid
Dosaggio dell'HVA e del 5-HIAA liquorali nelle sindromi epilettiche in condizioni di base e dopo trattamento con probenecid.